C2 PHARMA is a pharmaceutical group established in 2014. It manufactures
and distributes active pharmaceutical ingredients (APls) and complex chemical compounds obtained from
natural and synthetic origins.
The current API product portfolio includes cyclopentolate, atropine, digoxin, homatropine,
pilocarpine, brimonidine, latanoprost, bimatoprost and reaches more than 100 pharmaceutical companies
across the United States, Western and Eastern Europe, South America, Asia, Middle-East and Africa.
VISIT COMPANY WEBSITE